2,4,8,12-Cyclotetradecatetraen-1-ol,5,9,13-trimethyl-2-(1-methylethyl)-, (1S,2Z,4E,8E,12E)- (72629-69-7)

Identification
Name:	2,4,8,12-Cyclotetradecatetraen-1-ol,5,9,13-trimethyl-2-(1-methylethyl)-, (1S,2Z,4E,8E,12E)-
Synonyms:	2,4,8,12-Cyclotetradecatetraen-1-ol,5,9,13-trimethyl-2-(1-methylethyl)-, [S-(Z,E,E,E)]-; (+)-Sarcophytol A;(S)-Sarcophytol A; Sarcophytol A
CAS:	72629-69-7
Molecular Formula:	C20H32 O
Molecular Weight:	0
InChI:	InChI=1/C20H32O/c1-15(2)19-13-12-17(4)10-6-8-16(3)9-7-11-18(5)14-20(19)21/h8,11-13,15,20-21H,6-7,9-10,14H2,1-5H3/b16-8+,17-12+,18-11+,19-13-/t20-/m0/s1
Molecular Structure:
Properties
Flash Point:	175.5°C
Boiling Point:	415.4°C at 760 mmHg
Density:	0.894g/cm³
Refractive index:	1.485
Flash Point:	175.5°C
Safety Data

Other Product

2,4,8,12-Cyclotetradecatetraen-1-ol,5,9,13-trimethyl-2-(1-methylethyl)-, (1S,2E,4E,8E,12E)-
2,4,8,12-Cyclotetradecatetraen-1-ol,5,9,13-trimethyl-2-(1-methylethyl)-, (1S,2Z,4Z,8E,12E)-
2,4,8,12-Cyclotetradecatetraen-1-ol,5,9,13-trimethyl-2-(1-methylethyl)-, (1S,2E,4Z,8E,12E)-
2,6,10,12-Cyclotetradecatetraen-1-ol,3,7,13-trimethyl-10-(1-methylethyl)-, acetate, (1S,2E,6E,10E,12E)- (9CI)
2,4,12-Cyclotetradecatriene-1,8-diol,5,13-dimethyl-9-methylene-2-(1-methylethyl)-, (1S,2Z,4E,8R,12E)-
2,4,12-Cyclotetradecatriene-1,8-diol,5,13-dimethyl-9-methylene-2-(1-methylethyl)-, (1S,2Z,4E,8S,12E)-
2,4,6,8,10,12-Tridecahexaenal,13-[(1S,4S,6R)- 4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]- hept-1-yl]-2,7,11-trimethyl-,(2E,4E,6E,8E,- 10E,12E)-
4,8,12,16,20-Docosapentaen-1-ol,5,9,13,17,21- pentamethyl-2-(1-methylethenyl)-,(4E,8E,- 12E,16E)-(-)-
4,8,13-Cyclotetradecatriene-1,3-diol,1,5,9-trimethyl-12-(1-methylethyl)-, (1S,3R,4E,8E,12S,13E)-
(2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraen-1-ol
Ferrate(2-),chloro[(4E,8E)-7-ethenyl-17- formyl-12-(1-hydroxy-5,9,13-trimethyl-4,8,- 12-tetradecatrienyl)-3,8,13-trimethyl-21H,- 23H-porphine-2,18-dipropanoato(4-)-kN21,- kN22,kN23,kN24]-,dihydrogen,(SP-5-13)-
2,5,7,11-Cyclotetradecatetraen-1-ol,1,5,11- trimethyl-8-(1-methylethyl)-,(2E,5E,7E,- 11E)-
2,4,6,8,10,14-Hexadecahexaenamide,13-hydroxy-N-[(1S)-2-methoxy-1-methylethyl]-2,10,12,14-tetramethyl-,(2E,4E,6E,8E,10Z,12R,13R,14E)-
2,4,6,8,10,14-Hexadecahexaenamide,13-hydroxy-N-[(1S)-2-methoxy-1-methylethyl]-2,10,12,14-tetramethyl-,(2E,4E,6Z,8E,10E,12R,13R,14E)-
2,4,6,8,10,14-Hexadecahexaenamide,13-hydroxy-N-[(1S)-2-methoxy-1-methylethyl]-2,10,12,14-tetramethyl-,(2E,4E,6E,8E,10E,12R,13R,14E)-
2,4,6,8,10,12,14,16-Heptadecaoctaen-1-ol,2,6,11,15-tetramethyl-17-[(1R)-2,6,6-trimethyl-2-cyclohexen-1-yl]-,(2E,4E,6E,8E,10E,12E,14E,16E)- (9CI)
2,4,6,8,10,12-Tridecahexaenal,2,7,11-trimethyl-13-(2,6,6-trimethyl-1-cyclohexen-1-yl)-,(2E,4E,6E,8E,10E,12E)-
2,4,6,8,10,12-Tridecahexaenoic acid,2,7,11-trimethyl-13-(2,6,6-trimethyl-1-cyclohexen-1-yl)-,(2E,4E,6E,8E,10E,12E)-
2,4,6,8,10,12,14,16-Heptadecaoctaenoicacid,17-(1-hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-2,6,11,15-tetramethyl-,(2E,4E,6E,8E,10E,12E,14E,16E)- (9CI)
1,5,9-Triazacyclotridec-12-en-2-one,9-[(2Z)-1-oxo-3-phenyl-2-propen-1-yl]-4-phenyl-, (4S,12E)-